Improved patient outcomes through dosage individualisation of the newer immunosuppressant drugs (2008–2011)

After organ transplantation, recipients need to take medicines continually to stop their immune system from rehecting their new organ. this treatment with immunosuppressant drugs is vital for long-term success of their graft. However, too many people are losing their transplant or are experiencing drug toxicity or infection due to poorly managed immunosuppression. The project aims to accurately define the best way to dose newer immunosuppressant drugs in Australian transplant population.
Grant type:
NHMRC Project Grant
Funded by:
National Health and Medical Research Council